{
  "openalex_id": "W4396598649",
  "doi": "https://doi.org/10.1158/1538-7445.sabcs23-po1-19-01",
  "title": "Abstract PO1-19-01: NRG-BR008: A Phase III Randomized Trial of Radiotherapy Optimization for Low-risk HER2-positive Breast Cancer (HERO)",
  "abstract": "Abstract Background: Breast radiotherapy (RT) is the standard of care for patients with early-stage breast cancer (BC) who undergo breast-conserving surgery (BCS). However, the magnitude of benefit of RT is less clear in BCS patients with low-risk disease who receive effective systemic therapy. Among patients with early-stage HER2-positive (HER2+) BC, 10-year locoregional recurrence has been reported as low as 1.5% following BCS, adjuvant chemotherapy and HER2-targeted therapy, and RT. Given these exceedingly favorable outcomes, with the addition of HER2-directed therapy, we seek to evaluate the feasibility of omitting RT among patients with early-stage HER2+ BC following BCS and appropriate systemic therapy. Methods: This is a phase III randomized trial for patients ≥40 years with early-stage, node-negative HER2+ (IHC/FISH) BC treated with BCS with negative margins and sentinel lymph node biopsy or axillary dissection. Patients undergoing primary surgery must have pathologic T1 (&amp;lt; 2 cm) N0 disease, while patients receiving neoadjuvant therapy must have clinical T1-2 (with radiographically T&amp;lt; 3.0 cm) N0 disease and exhibit a pathologic complete response (ypT0N0) at surgery. All patients must receive cytotoxic chemotherapy and HER2-targeted therapy, either in the adjuvant or neoadjuvant setting. Stratification is by age (&amp;lt; 60; ≥60), tumor size (≤1 cm; &amp;gt;1 cm), estrogen-receptor status (positive; negative), and systemic therapy sequencing (adjuvant vs neoadjuvant). Patients will be randomized to standard breast RT in addition to continuation of trastuzumab to complete a year of treatment (Arm 1), or trastuzumab alone (Arm 2). Endocrine therapy will be recommended for patients with hormone-receptor positive tumors. The primary endpoint is the recurrence-free interval (RFI). Secondary endpoints include the time to ipsilateral breast recurrence, locoregional recurrence, disease-free survival, and overall survival, in addition to the 7-year ipsilateral breast recurrence rate among those not receiving RT. A health-related quality of life sub-study will assess differences in patient-reported breast pain and worry. We estimate a 7-year RFI of 97.5% with RT and allow for a clinically acceptable decrement of 3.63% without RT (7-year RFI of 93.87%; HR 2.5) to establish omission of RT as non-inferior. NRG-BR008 aims to enroll 1,300 patients over 4.5 years, yielding 80% power to detect the non-inferiority of RT omission with a one-sided α=0.05. We expect to observe the required 38 RFI events within 6 years of additional follow-up. The NRG-BR008/HERO trial opened to accrual in March, 2023. NCT05705401. Support: U10CA180868, -180822, UG1CA189867, U24CA196067; Susan G. Komen Foundation (JR) Citation Format: Lior Braunstein, Melissa Mitchell, Hanna Bandos, William Sikov, Atif Khan, Peter Chen, Patricia Ganz, Reshma Jagsi, Julia White, Reena Cecchini, Hyejoo Kang, Shannon Puhalla, Kelly Bolton, Eileen Connolly, Erica Stringer-Reasor, Kimberly Gergelis, Thomas Julian, Eleftherios Mamounas, Norman Wolmark. NRG-BR008: A Phase III Randomized Trial of Radiotherapy Optimization for Low-risk HER2-positive Breast Cancer (HERO) [abstract]. In: Proceedings of the 2023 San Antonio Breast Cancer Symposium; 2023 Dec 5-9; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2024;84(9 Suppl):Abstract nr PO1-19-01.",
  "authors": [
    {
      "display_name": "Lior Z. Braunstein",
      "id": "A5034069802",
      "orcid": "https://orcid.org/0000-0002-5127-0217",
      "institutions": [
        {
          "id": "I39965400",
          "display_name": "Kettering University",
          "country_code": "US",
          "type": "funder"
        },
        {
          "id": "I1334819555",
          "display_name": "Memorial Sloan Kettering Cancer Center",
          "country_code": "US",
          "type": "healthcare"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "Lior Braunstein"
    },
    {
      "display_name": "Melissa P. Mitchell",
      "id": "A5090279568",
      "orcid": "https://orcid.org/0000-0003-4390-9372",
      "institutions": [
        {
          "id": "I1343551460",
          "display_name": "The University of Texas MD Anderson Cancer Center",
          "country_code": "US",
          "type": "healthcare"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "Melissa Mitchell"
    },
    {
      "display_name": "Hanna Bandos",
      "id": "A5063900632",
      "orcid": "https://orcid.org/0000-0003-1798-8054",
      "institutions": [
        {
          "id": "I4210162619",
          "display_name": "NRG Oncology",
          "country_code": "US",
          "type": "nonprofit"
        },
        {
          "id": "I170201317",
          "display_name": "University of Pittsburgh",
          "country_code": "US",
          "type": "funder"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "Hanna Bandos"
    },
    {
      "display_name": "William M. Sikov",
      "id": "A5045617170",
      "orcid": "https://orcid.org/0000-0001-5451-6449",
      "institutions": [
        {
          "id": "I4210133025",
          "display_name": "Women & Infants Hospital of Rhode Island",
          "country_code": "US",
          "type": "healthcare"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "William Sikov"
    },
    {
      "display_name": "Atif Khan",
      "id": "A5067538693",
      "orcid": null,
      "institutions": [],
      "is_corresponding": false,
      "raw_author_name": "Atif Khan"
    },
    {
      "display_name": "Peter Chen",
      "id": "A5100651978",
      "orcid": "https://orcid.org/0000-0002-5330-1718",
      "institutions": [
        {
          "id": "I2799370151",
          "display_name": "Beaumont Health",
          "country_code": "US",
          "type": "nonprofit"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "Peter Chen"
    },
    {
      "display_name": "Patricia A. Ganz",
      "id": "A5103153387",
      "orcid": "https://orcid.org/0000-0002-1841-4143",
      "institutions": [
        {
          "id": "I4390039293",
          "display_name": "UCLA Jonsson Comprehensive Cancer Center",
          "country_code": null,
          "type": "healthcare"
        },
        {
          "id": "I2799798094",
          "display_name": "UCLA Health",
          "country_code": "US",
          "type": "healthcare"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "Patricia Ganz"
    },
    {
      "display_name": "Reshma Jagsi",
      "id": "A5076973801",
      "orcid": "https://orcid.org/0000-0001-6562-1228",
      "institutions": [
        {
          "id": "I4210111179",
          "display_name": "Michigan United",
          "country_code": "US",
          "type": "nonprofit"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "Reshma Jagsi"
    },
    {
      "display_name": "Julia White",
      "id": "A5061018265",
      "orcid": null,
      "institutions": [
        {
          "id": "I4210106879",
          "display_name": "Ohio University",
          "country_code": "US",
          "type": "funder"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "Julia White"
    },
    {
      "display_name": "Reena S. Cecchini",
      "id": "A5006334177",
      "orcid": "https://orcid.org/0000-0002-9075-9357",
      "institutions": [
        {
          "id": "I170201317",
          "display_name": "University of Pittsburgh",
          "country_code": "US",
          "type": "funder"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "Reena Cecchini"
    },
    {
      "display_name": "Hyejoo Kang",
      "id": "A5022223056",
      "orcid": "https://orcid.org/0000-0002-4433-0939",
      "institutions": [
        {
          "id": "I1925986",
          "display_name": "Loyola University Chicago",
          "country_code": "US",
          "type": "funder"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "Hyejoo Kang"
    },
    {
      "display_name": "Shannon Puhalla",
      "id": "A5113169602",
      "orcid": null,
      "institutions": [
        {
          "id": "I4210128526",
          "display_name": "UPMC Hillman Cancer Center",
          "country_code": "US",
          "type": "funder"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "Shannon Puhalla"
    },
    {
      "display_name": "Kelly L. Bolton",
      "id": "A5035097079",
      "orcid": "https://orcid.org/0000-0001-6584-3357",
      "institutions": [],
      "is_corresponding": false,
      "raw_author_name": "Kelly Bolton"
    },
    {
      "display_name": "Eileen P. Connolly",
      "id": "A5033835581",
      "orcid": "https://orcid.org/0000-0001-6558-1932",
      "institutions": [
        {
          "id": "I2799503643",
          "display_name": "Columbia University Irving Medical Center",
          "country_code": "US",
          "type": "healthcare"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "Eileen Connolly"
    },
    {
      "display_name": "Erica Stringer-Reasor",
      "id": "A5039952665",
      "orcid": "https://orcid.org/0000-0002-1862-3367",
      "institutions": [
        {
          "id": "I32389192",
          "display_name": "University of Alabama at Birmingham",
          "country_code": "US",
          "type": "funder"
        },
        {
          "id": "I4390039376",
          "display_name": "O'Neal Comprehensive Cancer Center",
          "country_code": null,
          "type": "healthcare"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "Erica Stringer-Reasor"
    },
    {
      "display_name": "Kimberly R. Gergelis",
      "id": "A5014169196",
      "orcid": "https://orcid.org/0000-0002-8130-8327",
      "institutions": [
        {
          "id": "I28792581",
          "display_name": "University of Rochester Medical Center",
          "country_code": "US",
          "type": "healthcare"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "Kimberly Gergelis"
    },
    {
      "display_name": "Thomas B. Julian",
      "id": "A5083023849",
      "orcid": "https://orcid.org/0000-0002-7460-3141",
      "institutions": [
        {
          "id": "I1310421338",
          "display_name": "Allegheny Health Network",
          "country_code": "US",
          "type": "healthcare"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "Thomas Julian"
    },
    {
      "display_name": "Eleftherios P. Mamounas",
      "id": "A5082509731",
      "orcid": "https://orcid.org/0000-0002-9476-2553",
      "institutions": [
        {
          "id": "I147878501",
          "display_name": "Orlando Health",
          "country_code": "US",
          "type": "healthcare"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "Eleftherios Mamounas"
    },
    {
      "display_name": "Norman Wolmark",
      "id": "A5055013606",
      "orcid": "https://orcid.org/0000-0001-7156-1110",
      "institutions": [
        {
          "id": "I4210128526",
          "display_name": "UPMC Hillman Cancer Center",
          "country_code": "US",
          "type": "funder"
        },
        {
          "id": "I4210162844",
          "display_name": "NSABP Foundation",
          "country_code": "US",
          "type": "nonprofit"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "Norman Wolmark"
    }
  ],
  "publication_year": 2024,
  "publication_date": "2024-05-02",
  "type": "article",
  "cited_by_count": 1,
  "is_retracted": false,
  "is_paratext": false,
  "language": "en",
  "source": {
    "id": "S168522863",
    "display_name": "Cancer Research",
    "issn_l": "0008-5472",
    "issn": [
      "0008-5472",
      "1538-7445"
    ],
    "type": "journal",
    "host_organization": "https://openalex.org/P4310320273"
  },
  "volume": "84",
  "issue": "9_Supplement",
  "first_page": "PO1",
  "last_page": "01",
  "open_access": {
    "is_oa": false,
    "oa_status": "closed",
    "oa_url": null,
    "any_repository_has_fulltext": false
  },
  "concepts": [
    {
      "id": "C530470458",
      "display_name": "Breast cancer",
      "level": 3,
      "score": 0.61667526
    },
    {
      "id": "C51364203",
      "display_name": "HERO",
      "level": 2,
      "score": 0.597415
    },
    {
      "id": "C71924100",
      "display_name": "Medicine",
      "level": 0,
      "score": 0.5759444
    },
    {
      "id": "C143998085",
      "display_name": "Oncology",
      "level": 1,
      "score": 0.5697124
    },
    {
      "id": "C509974204",
      "display_name": "Radiation therapy",
      "level": 2,
      "score": 0.5493462
    },
    {
      "id": "C126322002",
      "display_name": "Internal medicine",
      "level": 1,
      "score": 0.48675418
    },
    {
      "id": "C168563851",
      "display_name": "Randomized controlled trial",
      "level": 2,
      "score": 0.44515097
    },
    {
      "id": "C121608353",
      "display_name": "Cancer",
      "level": 2,
      "score": 0.42158204
    },
    {
      "id": "C29456083",
      "display_name": "Gynecology",
      "level": 1,
      "score": 0.34609097
    },
    {
      "id": "C142362112",
      "display_name": "Art",
      "level": 0,
      "score": 0.066336095
    },
    {
      "id": "C124952713",
      "display_name": "Literature",
      "level": 1,
      "score": 0.0
    }
  ],
  "topics": [
    {
      "id": "T10183",
      "display_name": "Breast Cancer Treatment Studies",
      "score": 0.9394
    }
  ],
  "created_date": null,
  "updated_date": null,
  "indexed_in": [],
  "landing_page_url": "https://doi.org/10.1158/1538-7445.sabcs23-po1-19-01",
  "pdf_url": null,
  "retrieved_date": "2025-07-30T14:57:12.925842",
  "source_database": "OpenAlex"
}